HealthTech Arkansas Hires Clinical Trials Manager for Trial Accelerator Program
HealthTech Arkansas announced today that it has hired Priya Bargoti as Clinical Trials Manager for the biophyle Trial accelerator program. In this role, Bargoti will coordinate and facilitate clinical trials between biophyle Trial’s participating early-stage biotherapeutics companies and the seven sites in Arkansas where they will conduct clinical trials.
Bargoti previously worked for Department of Defense agencies – the Defense Health Agency and the Navy Medical Research Center – managing projects in strategic data analysis and operational management.
About HealthTech Arkansas
HealthTech Arkansas helps to drive innovation for healthcare provider organizations through its accelerator programs and through internal innovation programming. Its flagship accelerator, HeartX, recruits worldwide for the most accomplished cardiovascular-focused startups in the areas of digital health, medical devices, and diagnostic platforms. Those companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among the ten largest hospitals and health systems in Arkansas. More information can be found at HealthTechArkansas.com.
“With 14 years of broad clinical trials experience with sites, sponsors and CROs, Priya brings an impressive set of skills to our organization,” said Jeff Stinson, director of HealthTech Arkansas. “I can’t wait to share her formidable talents with the BioAR Trial cohort companies and our sites in Arkansas as we strive to deliver outstanding clinical trials experiences.”
“I look forward to joining the dynamic team at HealthTech Arkansas and supporting the organization’s mission to increase access to innovative care in Arkansas. I aim to form strong bonds with providers and implement efficient methodologies to ensure successful administration of the clinical trials in the biophyle Trial accelerator program,” said Bargoti.
“We are thrilled to welcome Priya, who brings a deep expertise in managing clinical trials, to the biophyle team,” said Jahan Ali, Vice President of Business Development at SymBiosis. “Her experience will be an asset to the program and to the participating companies.”